RTOG-0131
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
A Phase II Trial of Pre-Irradiation and Concurrent Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendrogliomas and Mixed Anaplastic Oligoastrocytomas
Principal Investigator
Status
Terminated
Date Opened To Accrual
July 30, 2002
Date of Study Termination
May 14, 2018
Disease Site
Brain [BN] CNS Metastatic Disease
Phase
II
Developmental Therapeutics
No
Primary Objective
Rate of post-chemotherapy, pre-irradiation therapy progression.
Data Collection Notice:
Data for this trial is being collected via the NRG/RTOG Data Center.
Patient Population
Unifocal or multifocal supratentorial pure or mixed anaplastic oligodendroglioma confirmed by central pathology review.
Target Accrual
37
Protocol Document
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
